Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors (NCT06773507) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-05-12 |
| BC008-1A Injection for Recurrent CNS WHO G4 Glioma (NCT06773481) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-04-07 |
| BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. (NCT06773312) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-02-28 |
Track Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.